Supriya Lifescience Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	1,880	1,191	898.57	1,518	1,236
Depreciation & Amortization	200.84	154.45	114.52	97.52	63.69
Other Amortization	3.6	3.66	3.63	3.66	3.92
Loss (Gain) From Sale of Assets	0.06	-	1.11	-	-
Other Operating Activities	-53.72	-44.76	-43.63	-87.74	123.52
Change in Accounts Receivable	-226.79	-270.19	305.19	-416.83	-218.7
Change in Inventory	-331	305.21	-234.58	-198.32	-230.22
Change in Accounts Payable	149.76	-46.59	152.56	-20.5	16.53
Change in Other Net Operating Assets	24.42	-159.85	-561.32	-407.88	-235.78
Operating Cash Flow	1,647	1,133	636.05	488.01	758.89
Operating Cash Flow Growth	45.34%	78.14%	30.34%	-35.69%	-34.61%
Capital Expenditures	-1,624	-1,457	-1,079	-599.04	-482.41
Sale of Property, Plant & Equipment	-	-	-	0.82	14.4
Investment in Securities	5.56	-385	-252.43	-	-
Other Investing Activities	95.76	105.81	94.99	-	-
Investing Cash Flow	-1,522	-1,736	-1,237	-598.22	-468.01
Short-Term Debt Repaid	-	-166.25	-46.7	-486.07	-92.73
Long-Term Debt Repaid	-1.08	-3.54	-2.78	-7.63	-23.93
Total Debt Repaid	-1.08	-169.79	-49.48	-493.7	-116.66
Net Debt Issued (Repaid)	-1.08	-169.79	-49.48	-493.7	-116.66
Issuance of Common Stock	-	-	-	2,000	-
Common Dividends Paid	-64.39	-48.29	-48.29	-43.91	-39.56
Other Financing Activities	-16.86	-5.51	-4.99	34.13	11.06
Financing Cash Flow	-82.33	-223.59	-102.76	1,497	-145.16
Miscellaneous Cash Flow Adjustments	-	0.01	-0.01	-	0.01
Net Cash Flow	41.98	-826.25	-703.26	1,386	145.73
Free Cash Flow	22.99	-323.48	-443.05	-111.03	276.48
Free Cash Flow Growth	-	-	-	-	-69.80%
Free Cash Flow Margin	0.33%	-5.67%	-9.61%	-2.10%	7.07%
Free Cash Flow Per Share	0.29	-4.02	-5.50	-1.38	3.78
Cash Interest Paid	16.86	5.51	4.99	36.58	38.74
Cash Income Tax Paid	591.79	376.45	306.8	609.62	299.94
Levered Free Cash Flow	-215.62	-498.56	-582.63	-165.84	73.81
Unlevered Free Cash Flow	-212.61	-476.12	-563.35	-139.6	99.31
Change in Working Capital	-383.61	-171.42	-338.15	-1,044	-668.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.